Singapore markets closed
  • Straits Times Index

    3,208.86
    -8.55 (-0.27%)
     
  • S&P 500

    4,288.05
    -11.65 (-0.27%)
     
  • Dow

    33,507.50
    -158.80 (-0.47%)
     
  • Nasdaq

    13,219.32
    +18.02 (+0.14%)
     
  • Bitcoin USD

    28,352.82
    +1,156.74 (+4.25%)
     
  • CMC Crypto 200

    607.89
    +29.12 (+5.03%)
     
  • FTSE 100

    7,588.40
    -19.68 (-0.26%)
     
  • Gold

    1,850.90
    -15.20 (-0.81%)
     
  • Crude Oil

    91.68
    +0.89 (+0.98%)
     
  • 10-Yr Bond

    4.5730
    0.0000 (0.00%)
     
  • Nikkei

    31,759.88
    -97.72 (-0.31%)
     
  • Hang Seng

    17,809.66
    +436.66 (+2.51%)
     
  • FTSE Bursa Malaysia

    1,418.76
    -5.41 (-0.38%)
     
  • Jakarta Composite Index

    6,961.46
    +21.57 (+0.31%)
     
  • PSE Index

    6,304.53
    -16.71 (-0.26%)
     

Is It Too Late to Buy Invitae Stock?

Is It Too Late to Buy Invitae Stock?

Invitae (NYSE: NVTA) is a promising business specializing in genetic testing, which could be the wave of the future in healthcare. Genetic tests can uncover mutations or variants in your DNA, which can help prevent illnesses and treat them more effectively. Invitae, for instance, has been incurring significant losses and is a bit of a risky company to invest in.